{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:32:09Z","timestamp":1793172729822,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ygyno.2018.04.562","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T07:32:30Z","timestamp":1525159950000},"page":"180-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Melanoma of the lower genital tract: Prognostic factors and treatment modalities"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-406X","authenticated-orcid":false,"given":"Angiolo","family":"Gadducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvestro","family":"Carinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-5601","authenticated-orcid":false,"given":"Giovanni Damiano","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.04.562_bb0005","first-page":"739","article-title":"Primary mucosal melanomas: a comprehensive review","volume":"5","author":"Mihajlovic","year":"2012","journal-title":"Int. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0010","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0015","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/ijc.28625","article-title":"Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis","volume":"134","author":"Bishop","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2017.06.006","article-title":"Adjuvant interferon-\u03b1 for the treatment of high-risk melanoma: an individual patient data meta-analysis","volume":"82","author":"Ives","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/CMR.0000000000000292","article-title":"The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis","volume":"26","author":"Danish","year":"2016","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0035","series-title":"Cancer: Principles and Practice of Oncology","first-page":"1643","article-title":"Cutaneous melanoma","author":"Slingluff","year":"2011"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jrr\/rrt120","article-title":"Working Group for Gynecological Tumors. Clinical trial of carbon ion radiotherapy for gynecological melanoma","volume":"55","author":"Karasawa","year":"2014","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-319-22539-5_8","article-title":"Chemotherapy for melanoma","volume":"167","author":"Wilson","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jaad.2017.04.1126","article-title":"The new paradigm of systemic therapies for metastatic melanoma","volume":"77","author":"Volpe","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0055","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/modpathol.2013.211","article-title":"Comparison of molecular abnormalities in vulvar and vaginal melanomas","volume":"27","author":"Aulmann","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0060","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0065","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1073\/pnas.1216013110","article-title":"Combined targeting of MEK and PI3K\/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo","volume":"110","author":"Posch","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2004.09.052","article-title":"Population-based incidence rates of malignant melanoma of the vulva in Germany","volume":"96","author":"Stang","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.AOG.0000271209.67461.91","article-title":"Vulvar melanoma: a multivariable analysis of 644 patients","volume":"110","author":"Sugiyama","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1525-1438.2001.01043.x","article-title":"Vulvar melanoma at the M.D. Anderson Cancer center: 25\u202fyears later","volume":"11","author":"Verschraegen","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0085","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3892\/ijmm.2014.1659","article-title":"A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker","volume":"33","author":"Heinzelmann-Schwarz","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2016.04.021","article-title":"Rare vulvar malignancies; incidence, treatment and survival in the Netherlands","volume":"142","author":"Pleunis","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0095","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/1097-0142(19930301)71:5<1893::AID-CNCR2820710528>3.0.CO;2-7","article-title":"Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960\u20131984","volume":"71","author":"Ragnarsson-Olding","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/CMR.0b013e32833684e8","article-title":"Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas","volume":"20","author":"Hu","year":"2010","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejogrb.2004.11.048","article-title":"Primary malignant melanoma of the vagina: a case report and review of the current treatment options","volume":"121","author":"G\u00f6kaslan","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.21873\/invivo.11036","article-title":"Primary vaginal melanoma, a rare and aggressive entity. A case report and review of the literature","volume":"31","author":"Kalampokas","year":"2017","journal-title":"In Vivo"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0115","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/AOG.0b013e3181fb8045","article-title":"Primary malignant melanoma of the vagina","volume":"116","author":"Frumovitz","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0120","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/IGC.0b013e3182a1ced8","article-title":"Treatment approach and outcomes of vaginal melanoma","volume":"23","author":"Kirschner","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3802\/jgo.2013.24.4.330","article-title":"Clinical outcome of 31 patients with primary malignant melanoma of the vagina","volume":"24","author":"Huang","year":"2013","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0130","first-page":"137908","article-title":"Vaginal primary malignant melanoma: a rare and aggressive tumor","volume":"2013","author":"Androutsopoulos","year":"2013","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.critrevonc.2011.03.008","article-title":"A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer","volume":"81","author":"Pusceddu","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00000372-200206000-00008","article-title":"Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature","volume":"24","author":"Rohwedder","year":"2002","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/LGT.0000000000000142","article-title":"Malignant melanoma of vulva and vagina: a histomorphological review and mutation analysis\u2014a single-center study","volume":"19","author":"Rouzbahman","year":"2015","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0150","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0155","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/modpathol.2013.211","article-title":"Comparison of molecular abnormalities in vulvar and vaginal melanomas","volume":"27","author":"Aulmann","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0160","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cncr.30473","article-title":"Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma","volume":"123","author":"Hou","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0165","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jaad.2014.08.019","article-title":"Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic review","volume":"71","author":"Murzaku","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1273::AID-CNCR24>3.0.CO;2-Z","article-title":"Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features","volume":"86","author":"Ragnarsson-Olding","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0175","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3892\/ol.2014.2357","article-title":"Malignant melanoma of the vagina: a case report and review of the literature","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02524343","article-title":"Primary vaginal melanoma: a critical analysis of therapy","volume":"11","author":"Miner","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/dc.23637","article-title":"Cytology of primary vaginal melanoma: an unusual report on fine needle aspiration","volume":"45","author":"Agarwal","year":"2017","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1068-607X(98)00052-3","article-title":"Primary malignant melanoma of the uterine cervix: case report and review of the literature","volume":"5","author":"Cantuaria","year":"1998","journal-title":"Prim. Care Update Ob Gyns."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0090-8258(89)90645-8","article-title":"Malignant melanoma of the uterine cervix: case report and review of the literature","volume":"32","author":"Mordel","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/CMR.0b013e32831993de","article-title":"Primary malignant amelanotic melanoma of the female genital tract: report of two cases and review of literature","volume":"19","author":"An","year":"2009","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0205","article-title":"A case of malignant melanoma of the uterine cervix with disseminated metastases throughout the vaginal wall","volume":"2017","author":"Noguchi","year":"2017","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/dc.20917","article-title":"Metastatic malignant melanoma of the uterine cervix: first diagnosed on liquid-based cytology","volume":"36","author":"Uz\u00fcm","year":"2008","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ajcp\/46.4.420","article-title":"Melanomas of the vagina","volume":"46","author":"Norris","year":"1966","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0220","series-title":"Diagnostic Gynecologic and Obstetric Pathology","first-page":"151","article-title":"Melanocytic lesions of the vulva","author":"Granter","year":"2011"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/PAS.0b013e318068420c","article-title":"Atypical genital nevi. A cinicopathologic analysis of 56 cases","volume":"32","author":"Gleason","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000377698","article-title":"Diagnostic immunohistochemistry in cutaneous neoplasia: an update","volume":"8","author":"Compton","year":"2015","journal-title":"Dermatopathology"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0235","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1470-2045(08)70254-7","article-title":"Management of primary melanoma of the female urogenital tract","volume":"9","author":"Piura","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCO.0b013e32830b0dda","article-title":"Management of melanomas of the female genital tract","volume":"20","author":"Sugiyama","year":"2008","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0245","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.14694\/EdBook_AM.2014.34.e277","article-title":"Management of vulvar and vaginal melanomas: current and future strategies","author":"Leitao","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0250","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcma.2011.06.006","article-title":"Primary malignant melanoma of the vagina with repeated local recurrences and brain metastasis","volume":"74","author":"Lin","year":"2011","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/ijgc-00009577-200209000-00017","article-title":"Imaging studies in patients with malignant melanoma in the female genital tract","volume":"12","author":"Takehara","year":"2002","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0260","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1245\/s10434-014-4215-3","article-title":"Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases","volume":"22","author":"Seifried","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/0090-8258(92)90300-8","article-title":"Management of vulvar melanoma","volume":"45","author":"Trimble","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0270","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/1097-0142(19940515)73:10<2626::AID-CNCR2820731026>3.0.CO;2-U","article-title":"Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group","volume":"73","author":"Phillips","year":"1994","journal-title":"Cancer"},{"issue":"9 Suppl 3","key":"10.1016\/j.ygyno.2018.04.562_bb0275","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/IGC.0000000000000198","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas","volume":"24","author":"Leitao","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2018.04.562_bb0280","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","article-title":"Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Dummer","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0285","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1158\/1078-0432.CCR-13-0739","article-title":"Phase II randomized trial comparing high-dose IFN-\u03b12b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma","volume":"19","author":"Lian","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0290","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2013.02.028","article-title":"Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy","volume":"129","author":"Janco","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008390-200412000-00012","article-title":"Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma","volume":"14","author":"Harting","year":"2004","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0300","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0002-9378(98)70320-5","article-title":"Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature","volume":"178","author":"Buchanan","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0305","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/gyno.1995.9966","article-title":"Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3\u202fmm of invasion","volume":"59","author":"Geisler","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0310","first-page":"190","article-title":"Primary melanoma of the vagina: a clinicopathologic analysis","volume":"74","author":"Reid","year":"1989","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0315","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/gyno.1998.5188","article-title":"Malignant melanoma of the vagina and locoregional control: radical surgery revisited","volume":"71","author":"Irvin","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0320","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/labinvest.2017.64","article-title":"Melanoma subtypes demonstrate distinct PD-L1 expression profiles","volume":"97","author":"Kaunitz","year":"2017","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0325","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0330","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0335","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.562_bb0340","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/cncr.30663","article-title":"A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: a trial of the ECOG-ACRIN Cancer Research Group (E2607)","volume":"123","author":"Kalinsky","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/1097-0142(19930701)72:1<143::AID-CNCR2820720127>3.0.CO;2-M","article-title":"Vulvar melanoma reconsidered","volume":"72","author":"Look","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.04.562_bb0350","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00004347-199907000-00013","article-title":"Primary malignant melanoma of the uterine cervix: case report with world literature review","volume":"18","author":"Clark","year":"1999","journal-title":"Int. J. Gynecol. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818308400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818308400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T13:21:33Z","timestamp":1571059293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818308400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0090825818308400"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.562","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma of the lower genital tract: Prognostic factors and treatment modalities","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}